Susquehanna raised its price target on Kindred Healthcare following its reaffirmed guidance. The firm noted guidance included its positive perspective on the new LTAC criteria legislation. The company feels it swill be manageable and is unlikely to have a major impact on earnings. Shares are Positive rated.
- Health Care Industry
- Investment & Company Information
- Kindred Healthcare